Daiichi Sankyo reports Q2 results; reaffirms FY2026 outlook
- Daiichi Sankyo press release (DSKYF): Q2 global revenue increased 19.7% year-over-year to 1.167 trillion yen, driven by the company’s global oncology medicines.
- Operating profit increased 34.4% year-over-year to 193.8 billion yen.
- Full fiscal year 2026 guidance remains unchanged. Global revenue is anticipated to reach 2.34 trillion yen with an operating profit of 320.0 billion yen.
Create Your Free Account to Keep Reading
Get the confidence to navigate an uncertain market with free breaking news and stock alerts.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.